Les bénéfices des suivis intensifs dans la communauté délivrés par des équipes mobiles auprès de patients atteints de troubles mentaux sévères sont bien établis à court ou moyen terme. Néanmoins, la question de l’évolution à plus long terme demeure. Nous ne savons pas si le soutien et les soins intensifs prodigués par ces programmes maintiennent leurs bénéfices dans le temps. La présente étude vise à explorer, à long terme, l’évolution de patients ayant terminé un tel programme.

Vingt-neuf patients souffrant de troubles mentaux sévères, réfractaires aux soins, traités par une équipe mobile lors de sa création entre 2007 et 2009 ont été évalués à nouveau entre 2016 et 2017, soit en moyenne 8,7 ans après leur inclusion. Nous avons examiné leur trajectoire de soins depuis leur sortie du programme et exploré quelles caractéristiques cliniques pouvaient être prédictives de l’amélioration au long cours du fonctionnement psychosocial et de la symptomatologie.

Les résultats révèlent le maintien d’une réduction significative du nombre d’hospitalisations à long terme ainsi qu’un pourcentage bas de rupture de suivi à la suite du programme. À la fois la sévérité de la clinique des patients à l’inclusion au programme et l’amélioration de cette même clinique après six mois de suivi prédisent l’amélioration au long cours, bien après la fin de la prise en soin de l’équipe mobile.

Ces données suggèrent que les équipes mobiles de suivi intensif dans le milieu peuvent poser les fondements durables d’un meilleur engagement dans les soins et d’un meilleur fonctionnement psychosocial à long terme.

Beneficial effects of Assertive Community Treatment (ACT) programs on patients with severe mental disorders are well established over short or medium term. However, studies that investigate long term clinical and psychosocial outcomes are remarkably scarce, and it is not known whether the support and intensive care delivered by these programs maintain their benefits over time, especially after discharge. Thus, the present study sought further understanding on this issue by evaluating long term clinical and psychosocial evolution of patients who had been treated by an ACT team in 2007. We investigated the nature of treatment interventions and the level of care since discharge from ACT, especially in terms of adherence to care and number of psychiatric hospitalizations. We also examined factors, at inclusion in the ACT program and after six months of treatment, that could predict better long-term outcomes.

Twenty-nine patients with severe mental disorders, characterized by the heavy use of inpatient facilities and refusal of care, were treated by an ACT team which was implmented between 2007 and 2009. They participated at that time in an initial study on the effect of the program and were therefore assessed at inclusion and again after six months of treatment. Between 2016 and 2017, the present follow up took place and patients were assessed again on their current psychosocial functioning, quality of life and intensity of symptoms, using the same scales as those administered in the initial study. This design allowed us to compare baseline with “early” (after six months) and “late” (after a mean of 8.7 years) effects of ACT program on patients. In order to assess adherence to care since discharge from ACT, data on nature and level of psychiatric treatment was systematically reviewed, including all public and private inpatient and outpatient treatments since the end of the ACT program.

Detailed tables on hospitalizations before, during and after ACT treatment are reported, as well as tables summarizing the level of care and nature of treatment since discharge from ACT. During the mean of 8.7 years of evolution and 6.3 years after discharge from ACT, these patients, characterized by severe mental disorders, heavy use of inpatient facilities and refusal of care, sustained a reduced rate of hospitalizations and a minor rate of disengagement from outpatient care (6.9 %). Both severity of symptoms, poorer quality of life and worst functioning in the community at inclusion (baseline) as well as early improvements (after six month of ACT treatment) of the same outcomes were significantly associated with long term improvements. Results also show other baseline predictors of long term improvement: fewer years since disorder onset was associated with improvement of functioning in the community; further advancement in the recovery process predicted better enhancement in quality of life, and a better initial functioning in the community was associated with a better improvement of symptomatology.

This study provides insight on the sustainability of the benefits of ACT programs, suggesting that these interventions can help patients who are refractory to care to gain clinical and psychosocial improvement in the long term. Our results also suggest that baseline severity as well as early improvements after six months of treatment were associated with larger improvement at follow up. These clinical predictors provide some help to distinguish which patients are more likely to benefit from an ACT approach.